Efficacy and safety of switching to long-acting cabotegravir + rilpivirine versus continuing bictegravir/emtricitabine/tenofovir alafenamide in Japanese participants: 12-month results from the phase 3b randomized SOLAR trial
Titel:
Efficacy and safety of switching to long-acting cabotegravir + rilpivirine versus continuing bictegravir/emtricitabine/tenofovir alafenamide in Japanese participants: 12-month results from the phase 3b randomized SOLAR trial
Auteur:
Adachi, Eisuke Yokomaku, Yoshiyuki Watanabe, Dai Gatanaga, Hiroyuki Oka, Shinichi Shirasaka, Takuma Wakatabe, Rumi Chamay, Nadine Sutton, Kenneth Sutherland-Phillips, Denise Urbaityte, Rimgaile D'Amico, Ronald van Wyk, Jean
Verschenen in:
Journal of infection and chemotherapy
Paginering:
Jaargang 31 () nr. 7 pagina's p.
Jaar:
2025
Inhoud:
Uitgever:
Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control